Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

STERIS plc Director's Dealing 2019

Mar 28, 2019

30229_dirs_2019-03-28_d20dab7c-bb08-4dd9-bbb0-43c0b407e7fa.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STERIS Ltd (STE)
CIK: 0001757898
Period of Report: 2019-03-28

Reporting Person: Wood Michael B (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-03-28 Ordinary Shares A 22331 Acquired 22331 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-03-28 Director Stock Option (right to buy) $32.34 A 3133 Acquired 2020-08-04 Ordinary Shares (3133) Direct
2019-03-28 Director Stock Option (right to buy) $31.61 A 3121 Acquired 2021-08-03 Ordinary Shares (3121) Direct
2019-03-28 Director Stock Option (right to buy) $32.36 A 3218 Acquired 2022-08-03 Ordinary Shares (3218) Direct
2019-03-28 Director Stock Option (right to buy) $51.53 A 4584 Acquired 2024-08-06 Ordinary Shares (4584) Direct
2019-03-28 Director Stock Option (right to buy) $64.05 A 4110 Acquired 2025-08-31 Ordinary Shares (4110) Direct
2019-03-28 Director Stock Option (right to buy) $71.40 A 3781 Acquired 2026-08-10 Ordinary Shares (3781) Direct
2019-03-28 Director Stock Option (right to buy) $86.23 A 4058 Acquired 2027-08-09 Ordinary Shares (4058) Direct
2019-03-28 Director Stock Option (right to buy) $114.74 A 3495 Acquired 2028-08-09 Ordinary Shares (3495) Direct
2019-03-28 Career Restricted Stock Units $ A 5192 Acquired Ordinary Shares (5192) Direct

Footnotes

F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.

F2: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F3: This option to purchase 3,121 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,121 Old STERIS ordinary shares for $31.61 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F4: This option to purchase 3,218 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,218 Old STERIS ordinary shares for $32.36 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F5: This option to purchase 4,584 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,584 Old STERIS ordinary shares for $51.53 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F6: This option to purchase 4,110 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,110 Old STERIS ordinary shares for $64.05 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F7: This option to purchase 3,781 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,781 Old STERIS ordinary shares for $71.40 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F8: This option to purchase 4,058 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 4,058 Old STERIS ordinary shares for $86.23 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F9: This option to purchase 3,495 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,495 Old STERIS ordinary shares for $114.74 per share, subject to the same terms and conditions as the original Old STERIS stock option.

F10: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 5,192 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement.